Furthermore, even moderate doses of aspirin are
associated with relative risks of hemorrhagic
events, including gastrointestinal bleeding, that
range from 1.5 to 3.1.9 More intensive antiplatelet
therapy through a different mechanism of action
may be more effective than aspirin at reducing
the risk of recurrent ischemia after transient
ischemic attack or acute ischemic stroke, but evidence
to support this is limited